Related Experiment Video

Updated: Jun 27, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina

Azeem Latib1, Alaide Chieffo, Antonio Colombo

  • 1Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy.

Nature Clinical Practice. Cardiovascular Medicine
|December 10, 2008
PubMed

Insights

For chronic stable angina, percutaneous coronary intervention (PCI) offers no survival benefit over optimal medical therapy (OMT). PCI may improve symptoms in severe cases, but OMT alone is effective for mild symptoms.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Chronic stable angina (CSA) management often involves revascularization strategies.
  • The COURAGE trial investigated the role of percutaneous coronary intervention (PCI) versus optimal medical therapy (OMT) in CSA patients.

Purpose of the Study:

  • To evaluate the impact of PCI plus OMT versus OMT alone on clinical outcomes and quality of life in patients with CSA.
  • To identify patient subgroups who may benefit most from PCI.

Main Methods:

  • A substudy of the COURAGE trial involving patients with CSA, normal left ventricular function, and moderate coronary artery disease.
  • Comparison of outcomes between patients receiving PCI plus OMT and those receiving OMT alone.

Main Results:

  • Both PCI plus OMT and OMT alone significantly improved quality of life and angina symptoms.
  • PCI provided substantial benefit for patients with more severe and frequent angina.
  • No significant difference in the risk of death or myocardial infarction between the two groups.

Conclusions:

  • For patients with CSA and moderate coronary artery disease, OMT alone is as effective as PCI plus OMT in reducing mortality and myocardial infarction risk.
  • PCI may offer additional symptomatic relief for select patients with severe angina.
  • OMT alone is a sufficient and effective strategy for patients with mild angina or no significant ischemia.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...